Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nabis is a specialized investment company focused on the global cannabis industry, with a primary emphasis on the United States market. The company strategically invests in high-quality assets across the cannabis value chain, including cultivation, processing, and retail operations. Nabis aims to build a diversified portfolio of cannabis-related businesses to capitalize on the expanding legal market and increasing consumer demand for cannabinoid-based products. By leveraging its expertise in capital markets and the cannabis sector, Nabis seeks to drive growth and value for its shareholders through strategic acquisitions and operational improvements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nabis.